Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 152
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

Can Data Management Tools Improve Research Efficiency and Reproducibility?

Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

What can we do to improve survival in babies with respiratory distress in Bangladesh?

Respiratory Distress is a treatable disease which kills hundreds of thousands of babies every year. Most of...

Backer Badge Funded